Corrigendum to "HDR Brachytherapy in the Management of High-Risk Prostate Cancer"

Adv Urol. 2016:2016:6345816. doi: 10.1155/2016/6345816. Epub 2016 Nov 21.

Authors

Susan Masson¹, Raj Persad², Amit Bahl¹

Affiliations

¹ Bristol Haematology and Oncology Centre, University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8ED, UK.
² Department of Urology, University Hospitals Bristol NHS Foundation Trust, Bristol BS2 8HW, UK.

Abstract

[This corrects the article DOI: 10.1155/2012/980841.].

Publication types

Published Erratum